Stay updated on Sotorasib in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Sotorasib in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Sotorasib in KRAS G12C NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference1%
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check34 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check63 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check77 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed study descriptions and inclusion criteria for a clinical trial on neoadjuvant sotorasib in patients with KRAS G12C mutated non-small cell lung cancer, while adding a new version revision and a mention of the study's location.SummaryDifference44%
- Check84 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Sotorasib in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotorasib in KRAS G12C NSCLC Clinical Trial page.